MedPath

Innovative Screening Approach: The Sensitivity and Specificity of Electrospun Containing Toluidine Blue Optimized Using Design of Experiment in the Detection of Oral Potentially Malignant Disorders

Phase 1
Completed
Conditions
a novel adjunctive approach for identifying dysplastic alterations in oral epithelial tissue.
Oral cancer
Registration Number
TCTR20240429002
Lead Sponsor
Royal College of Dental Surgeons of Thailand
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
36
Inclusion Criteria

1. Male or female, age > 20 years old
2. Patients who are suspected of having oral potentially malignant disorders
3. Patients with non-healing ulcer > 2 weeks
4. Patients who can be followed up
5. Patients who give their consent for the study

Exclusion Criteria

1. Patients with severe systemic diseases
2. Patients having obvious invasive carcinomas
3. Patients who abandoned treatment
4. Patients who refuse to join the study
5. Patients who are allergic to toluidine blue, acetic acid, polyvinylpyrrolidone or local anesthetic agents
6. Patients who deny tissue biopsy with toluidine blue

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Sensitivity 3 months after intervention Compare with pathologic evaluation,Specificity 3 months after intervention Compare with pathologic evaluation
Secondary Outcome Measures
NameTimeMethod
Sex after end of the intervention using a questionnaire interview,Age after end of the intervention using a questionnaire interview,Location of lesion after end of the intervention using clinical evaluation,Habit after end of the intervention using a questionnaire interview
© Copyright 2025. All Rights Reserved by MedPath